David Pendarvis - Nov 23, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Nov 23, 2022
Transactions value $
-$1,550,828
Form type
4
Date filed
11/23/2022, 04:37 PM
Previous filing
Nov 15, 2022
Next filing
Nov 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +12.4K +12.23% $0.00 114K Nov 23, 2022 Direct F1
transaction RMD ResMed Common Stock Tax liability -$1.55M -6.91K -6.08% $224.40 107K Nov 23, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.
F2 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.